Endocrine Adverse Events in Cancer Immunotherapy: From Mechanisms to Clinical Practice

<p id="p1">Immunotherapy-induced endocrinopathies remain an adverse risk factor for patients undergoing PD-1/PD-L1 and CTLA-4 target immunotherapy treatment. Immunotherapy works by boosting the immune system to target, bind and block tumor receptors that would otherwise allow the cells to camouflage...

Descripción completa

Detalles Bibliográficos

Autores principales:	Aseyev, Olexiy, Bishop, Alesha, Shortreed, Hannah, Monaghan, Elycia, Sun, Yue
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2024
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/1173340
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!